2019
DOI: 10.1002/stem.3053
|View full text |Cite
|
Sign up to set email alerts
|

CD166 Engagement Augments Mouse and Human Hematopoietic Progenitor Function via Activation of Stemness and Cell Cycle Pathways

Abstract: Hematopoietic stem (HSC) and progenitor (HPC) cells are regulated by interacting signals and cellular and noncellular elements of the hematopoietic niche. We previously showed that CD166 is a functional marker of murine and human HSC and of cellular components of the murine niche. Selection of murine CD166 + engrafting HSC enriched for marrow repopulating cells. Here, we demonstrate that CD166-CD166 homophilic interactions enhance generation of murine and human HPC in vitro and augment hematopoietic function o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 39 publications
(54 reference statements)
0
6
0
Order By: Relevance
“…It has been reported that the surface markers such as CD133, in combination with CD29/CD24 and CD44/CD166, may correlate with high Wnt activity and identify stem cells in various tumour types and their possible interaction with the microenvironment [51]. Interestingly, in BC ADSCs, the markers CD144, CD146, CD166, and KDR result significantly deregulated suggesting oncogenic alteration also in the tumour microenvironment with a possible role in favouring angiogenesis, tumour cell migration, and proliferation [52].…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that the surface markers such as CD133, in combination with CD29/CD24 and CD44/CD166, may correlate with high Wnt activity and identify stem cells in various tumour types and their possible interaction with the microenvironment [51]. Interestingly, in BC ADSCs, the markers CD144, CD146, CD166, and KDR result significantly deregulated suggesting oncogenic alteration also in the tumour microenvironment with a possible role in favouring angiogenesis, tumour cell migration, and proliferation [52].…”
Section: Discussionmentioning
confidence: 99%
“…Progenitor assays were performed to determine whether recombinant CD166 (rCD166) and Embigin (rEmb) could substitute for OM activity in vitro. BSA (control), rCD166, and rEmb were coated onto tissue culture plates ( Zhang et al., 2019 ), which were used to culture OB (from NCC). No significant differences in CFU fold change were observed between OM+OB, rCD166+OB, rEmb+OB, and rCD166+rEmb+OB, indicating that rCD166 and rEmb could partially substitute for OM-mediated enhancement of hematopoietic activity ( Figure 5 E).…”
Section: Resultsmentioning
confidence: 99%
“…CD166 studies were more expansive due to prior laboratory experience and availability of CD166 KO mice ( Cheng et al., 2011 ; Chitteti et al., 2010a , 2014 ; Xu et al., 2016 ). We previously demonstrated in multiple settings the importance of CD166 in maintaining HSC and progenitor cell function and the competence of the hematopoietic niche ( Cheng et al., 2011 ; Chitteti et al., 2010a , 2014 ; Zhang et al., 2019 ). Here, we demonstrated that OM function is also dependent on CD166 expression.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that immature osteolineage cells are potent in expanding HSPC in vitro compared with mature osteoblasts. CD166, another protein expressed on immature osteoblasts, is also critical for maintenance of HSPC in vitro and homophilic engagement of CD166 expressed on osteoblasts and HSPC is required for HEA [51,52].…”
Section: Role Of Osteoblasts In the Hematopoietic Nichementioning
confidence: 99%